Website of the Department of Health
Please note that this website has a UK government access keys system.
Page menu
Archive
- Acupuncture Regulatory Working Group (ARWG)
- Advisory Committee on Genetic Testing (ACGT)
- Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation (MSBTO)
- Advisory Group on the Reform of the NHS (Pharmaceutical Services) Regulations 1992 (AGRNHS)
- Committee on Medical Aspects of Food and Nutrition Policy (COMA)
- Cosmetic Surgery Steering Group
- Eye Care Services Steering Group
- Herbal Medicine Regulatory Working Group (HMRWG)
- Human Genetics Advisory Commission (HGAC)
- Independent Review of NHS Pathology Services (IRNHSPS)
- Maternity and Neonatal Workforce Group (MNWG)
- Medical Practices Committee
- Medicines (Administration of Radioactive Substances) Regulations 1978 (MARSR)
- National Specialist Commissioning Advisory Group (NSCAG)
- Nutrition Forum
- Paediatric & Congenital Cardiac Services Review Group (PCCSRG)
- Productive Time Delivery Board (PTDB)
- Pharmaceutical Industry Competitiveness Task Force (PICTF)
- Scientific Pandemic Influenza Advisory Group (SAG)
- Specialist Advisory Committee on Antimicrobial Resistance (SACAR)
- Standing Dental Advisory Committee (SDAC)
- Standing Medical Advisory Committee (SMAC)
- Standing Nursing and Midwifery Advisory Committee (SNMAC)
- Technical Working Group on Personal Social Services Statistics (TWGPSSS)
- UK National Influenza Pandemic Committee (UKNIPC)
- UK Xenotransplantation Interim Regulatory Authority (UKXIRA)
- Unlinked Anonymous Surveys Steering Group (UASSG)
- Unrelated Live Transplant Regulatory Authority (ULTRA)
You are here:
Unlinked Anonymous Surveys Steering Group (UASSG)
As the Unlinked Anonymous Prevalence Monitoring Programme is well-established and stable, the UASSG has not met since 2004. However, the Health Protection Agency, which provides the secretariat to the Group, keeps the need for the Group to reconvene under review in conjunction with the Department of Health.
Terms of reference
To steer the unlinked anonymous (UA) prevalence monitoring programme, specifically to:-
- advise on the programme, its performance and the value for money of the surveys for HIV, hepatitis B and hepatitis C and prospective national surveys for other infectious diseases as agreed by Ministers
- review the programme on an ongoing and structured basis to ensure that the surveys continue to meet ministerial priorities and results are used to inform public health issues
- oversee the use of the UA archive, with delegated authority from Ministers to approve requests for retrospective testing of archived samples collected as part of the UA programme (in England and Wales) for other infectious diseases of public health importance
- review and make recommendations on proposals related to development of the programme of UA serosurveillance for blood-borne viruses in England, and Wales, including identifying priorities for use of development monies
- provide commentary on the annual report summarising the key results of the programme before publication
- provide any other advice on issues relating to the unlinked anonymous survey programme referred to the Group by the Programme Manager or Secretariat.
Unlinked Anonymous Prevalence Monitoring Programme
The Unlinked Anonymous Prevalence Monitoring Programme which began in 1990 aims to measure the distribution of infection, in particular HIV, in accessible groups of the adult population. The programme has a number of objectives, including assessing the effectiveness of voluntary confidential testing for clinical diagnosis of HIV infection.
The data obtained are used to target and evaluate health promotion, to inform estimates of the numbers requiring treatment and care in the future, and to plan services for those affected by HIV and AIDS. Summaries of the data are published in Annual Reports.
Additional links
Useful links
- Expert Advisory Group on AIDS (EAGA)
- Advisory Group on Hepatitis (AGH)
- NHA Direct: HIV and AIDS (opens new window)
- Health Protection Agency: HIV (opens new window)
- Health Protection Agency: Overall HIV prevalence (opens new window)
- National Study of HIV in Pregnancy and Childhood (NSHPC) (opens new window)
- Health Protection Scotland (opens new window)
- Better prevention, better services, better sexual health - The national strategy for sexual health and HIV
- Response to the consultation on the national strategy for sexual health and HIV (opens new window)
Global links
Access keys
- Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI)
- Scientific Committee on Tobacco and Health (SCOTH)
- Joint Committee on Vaccination and Immunisation (JCVI)
- Advisory Committee on Dangerous Pathogens (ACDP)
- Advisory Committee on Clinical Excellence Awards (ACCEA)
- Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI)
